B cell receptor inhibitor causes chronic lymphocytic leukemia remission
Sunday, December 11, 2011 - 14:30
in Health & Medicine
A new, targeted approach to treating chronic lymphocytic leukemia has produced durable remissions in a Phase I/II clinical trial for patients with relapsed or resistant disease, researchers report.
